InvestorsHub Logo
Followers 23
Posts 3090
Boards Moderated 0
Alias Born 08/05/2019

Re: None

Saturday, 08/01/2020 12:28:20 PM

Saturday, August 01, 2020 12:28:20 PM

Post# of 2676
Leveraging manufacturing technology to CBD

Zynerba utilizes an established pharmaceutical manufacturing process to replicate the structure and function of the CBD found in the Cannabis plant. Lot consistency, reproducibility, purity and supply are required elements of any pharmaceutical manufacturing process. Zynerba believes that its manufacturing process will allow it to reproducibly manufacture its transdermal CBD gel to meet the stringent global regulatory agencies’ standards while ensuring consistent and efficient supply – without the costs and logistical requirements of growing and harvesting Cannabis.

Our commitment to patients drives our research efforts into pharmaceutically manufactured CBD – the same structure and function, without plants

https://zynerba.com/our-focus/why-pharmaceutical-manufacturing/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ZYNE News